Brave C&H SupplyLtd Bilan de santé

Santé financière contrôle des critères 5/6

Brave C&H SupplyLtd possède un total de capitaux propres de NT$2.0B et une dette totale de NT$533.8M, ce qui porte son ratio d'endettement à 27%. Son actif total et son passif total sont NT$3.6B et de NT$1.6B. L'EBIT de Brave C&H SupplyLtd est NT$653.5M ce qui fait que son ratio de couverture des intérêts -152.3. Elle dispose de liquidités et de placements à court terme de NT$819.5M.

Informations clés

27.0%

Ratio d'endettement

NT$533.78m

Dette

Ratio de couverture des intérêts	-159.1x
Argent liquide	NT$819.45m
Fonds propres	NT$1.98b
Total du passif	NT$1.58b
Total des actifs	NT$3.56b

Mises à jour récentes de la santé financière

Is Brave C&H SupplyLtd (GTSM:6538) A Risky Investment?

Feb 26

Recent updates

Investors Shouldn't Overlook Brave C&H SupplyLtd's (GTSM:6538) Impressive Returns On Capital

Apr 05

Could The Market Be Wrong About Brave C&H Supply Co.,Ltd. (GTSM:6538) Given Its Attractive Financial Prospects?

Mar 18

Is Brave C&H SupplyLtd (GTSM:6538) A Risky Investment?

Feb 26

Brave C&H SupplyLtd (GTSM:6538) Has Rewarded Shareholders With An Exceptional 531% Total Return On Their Investment

Feb 09

Things Look Grim For Brave C&H Supply Co.,Ltd. (GTSM:6538) After Today's Downgrade

Jan 19

A Look At The Fair Value Of Brave C&H Supply Co.,Ltd. (GTSM:6538)

Jan 12

Brave C&H SupplyLtd (GTSM:6538) Knows How To Allocate Capital Effectively

Dec 22

Brave C&H Supply Co.,Ltd.'s (GTSM:6538) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Dec 04

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 6538 ( NT$2.4B ) dépassent ses passifs à court terme ( NT$1.3B ).

Passif à long terme: Les actifs à court terme de 6538 ( NT$2.4B ) dépassent ses passifs à long terme ( NT$323.6M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 6538 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 6538 est passé de 13.4% à 27% au cours des 5 dernières années.

Couverture de la dette: La dette de 6538 est bien couverte par le flux de trésorerie opérationnel ( 57.6% ).

Couverture des intérêts: 6538 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

Brave C&H SupplyLtd Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Is Brave C&H SupplyLtd (GTSM:6538) A Risky Investment?

Recent updates

Investor sentiment deteriorates as stock falls 17%

Second quarter 2024 earnings released: EPS: NT$3.71 (vs NT$1.82 in 2Q 2023)

Now 21% overvalued

Investor sentiment deteriorates as stock falls 19%

Upcoming dividend of NT$7.01 per share

First quarter 2024 earnings released: EPS: NT$2.95 (vs NT$0.99 in 1Q 2023)

Brave C&H Supply Co.,Ltd., Annual General Meeting, May 30, 2024

Full year 2023 earnings released: EPS: NT$9.11 (vs NT$4.57 in FY 2022)

Investor sentiment improves as stock rises 15%

Third quarter 2023 earnings released: EPS: NT$3.49 (vs NT$1.32 in 3Q 2022)

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 20%

Second quarter 2023 earnings released: EPS: NT$1.82 (vs NT$1.08 in 2Q 2022)

Upcoming dividend of NT$3.30 per share at 2.2% yield

New major risk - Share price stability

Investor sentiment improves as stock rises 20%

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: NT$4.57 (vs NT$4.13 in FY 2021)

Price target decreased to NT$86.00

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$1.32 (vs NT$0.90 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$1.08 (vs NT$0.77 in 2Q 2021)

Upcoming dividend of NT$2.50 per share

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment improved over the past week

Price target decreased to NT$86.00

Less than half of directors are independent

Now 21% undervalued

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS NT$0.90 (vs NT$3.34 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$7.00 per share

Second quarter 2021 earnings released: EPS NT$0.77 (vs NT$2.61 in 2Q 2020)

Price target decreased to NT$93.00

Investor sentiment improved over the past week

Consensus forecasts updated

First quarter 2021 earnings released: EPS NT$1.52 (vs NT$3.60 in 1Q 2020)

Investor sentiment deteriorated over the past week

Price target decreased to NT$123

Investors Shouldn't Overlook Brave C&H SupplyLtd's (GTSM:6538) Impressive Returns On Capital

Consensus EPS estimates fall to NT$7.27

Full year 2020 earnings released: EPS NT$11.52 (vs NT$7.63 in FY 2019)

Could The Market Be Wrong About Brave C&H Supply Co.,Ltd. (GTSM:6538) Given Its Attractive Financial Prospects?

New 90-day low: NT$151

Is Brave C&H SupplyLtd (GTSM:6538) A Risky Investment?

Brave C&H SupplyLtd (GTSM:6538) Has Rewarded Shareholders With An Exceptional 531% Total Return On Their Investment

New 90-day low: NT$156

Price target lowered to NT$145

Things Look Grim For Brave C&H Supply Co.,Ltd. (GTSM:6538) After Today's Downgrade

A Look At The Fair Value Of Brave C&H Supply Co.,Ltd. (GTSM:6538)

New 90-day low: NT$176

Brave C&H SupplyLtd (GTSM:6538) Knows How To Allocate Capital Effectively

New 90-day low: NT$180

Brave C&H Supply Co.,Ltd.'s (GTSM:6538) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Third quarter 2020 earnings released: EPS NT$3.33

Earnings beat expectations, revenue disappoints

Analysts lower EPS estimates to NT$11.95

Price target lowered to NT$241

Price target raised to NT$289

New 90-day high - NT$280

Price target raised to NT$272

New 90-day high - NT$246

New 90-day high - NT$245

Price target lowered to NT$301

First half earnings released

New 90-day low - NT$209

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines